In the last trading session, 9.71 million Oragenics Inc (AMEX:OGEN) shares changed hands as the company’s beta touched 0.85. With the company’s per share price at $0.28 changed hands at -$0.01 or -2.34% during last session, the market valuation stood at $3.57M. OGEN’s last price was a discount, traded about -1328.57% off its 52-week high of $4.00. The share price had its 52-week low at $0.25, which suggests the last value was 10.71% up since then. When we look at Oragenics Inc’s average trading volume, we note the 10-day average is 0.24 million shares, with the 3-month average coming to 854.64K.

Oragenics Inc (AMEX:OGEN) trade information

Instantly OGEN was in red as seen at the end of in last trading. With action -6.85%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -23.07%, with the 5-day performance at -6.85% in the red. However, in the 30-day time frame, Oragenics Inc (AMEX:OGEN) is -21.06% down. Looking at the short shares, we see there were 0.19 million shares sold at short interest cover period of 0.43 days.

Oragenics Inc (AMEX:OGEN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 25.41% of Oragenics Inc shares while 11.13% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 14.92%.

Among Mutual Funds, the top two as of Nov 30, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 29.56 shares estimated at $8398.0 under it, the former controlled 0.24% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.07% of the shares, roughly 8.87 shares worth around $2518.0.